Julie Crockett

A Phase 2, Double‐Blind, Placebo‐Controlled Trial to Investigate Potential Drug‐Drug Interactions Between Cannabidiol and Clobazam

K. VanLandingham, Gilmour Morrison, Julie Crockett, 2020, Journal of clinical pharmacology.

A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy

E. Ben-Menachem, B. Gunning, K. VanLandingham, 2020, CNS Drugs.

A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment

Gilmour Morrison, Bola Tayo, Julie Crockett, 2019, Journal of clinical pharmacology.

A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects

D. Critchley, J. Berwaerts, Gilmour Morrison, 2020, Epilepsia.

A Phase 1, Open‐Label, Pharmacokinetic Trial to Investigate Possible Drug‐Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects

K. Sommerville, Gilmour Morrison, Julie Crockett, 2019, Clinical pharmacology in drug development.

Abrupt withdrawal of cannabidiol (CBD): A randomized trial

K. Sommerville, Bola Tayo, Julie Crockett, 2020, Epilepsy & Behavior.